Anika Therapeutics, Inc.
ANIK
$9.72
-$0.04-0.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.17M | -8.84M | -4.96M | -4.60M | -67.60M |
| Total Depreciation and Amortization | 4.26M | 2.86M | 3.65M | 4.12M | 7.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.15M | 9.77M | 8.42M | 11.51M | 77.18M |
| Change in Net Operating Assets | 308.00K | -4.10M | -8.31M | -12.22M | -14.83M |
| Cash from Operations | 6.55M | 4.70M | 3.82M | 3.82M | 7.46M |
| Capital Expenditure | -6.18M | -4.29M | -6.23M | -5.21M | -7.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 4.50M | 4.50M | -- | -- | -- |
| Other Investing Activities | 1.08M | 928.00K | 4.50M | -- | -- |
| Cash from Investing | -599.00K | -683.00K | -3.55M | -7.03M | -8.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 261.00K | 261.00K | 464.00K | 487.00K | 822.00K |
| Repurchase of Common Stock | -5.53M | -5.52M | -7.01M | -3.87M | -3.86M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.27M | -9.25M | -10.54M | -7.38M | -7.03M |
| Foreign Exchange rate Adjustments | 151.00K | 453.00K | -116.00K | -255.00K | -179.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 831.00K | -4.45M | -10.05M | -10.50M | -8.28M |